Cytek Biosciences Inc expected to post earnings of 5  cents a share - Earnings Preview

Cytek Biosciences

25/02/2023 03:01

* Cytek Biosciences Inc  CTKB.OQ   CTKB.O  is expected
to show a
rise in quarterly revenue when it reports  results on February
28. 
    * The Fremont California-based  company is expected to
report  a
29.1% increase in revenue to $50.22 million from $38.89 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cytek Biosciences
Inc is
for earnings of 5 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cytek
Biosciences
Inc is $16.5​, above​ its last closing price of $11.16. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  0.02        0.02       0.04      Beat    100
 Jun. 30 2022  0.03        0.02       0.03      Beat    80
 Mar. 31 2022  -0.01       0.00       0.01      Beat    300​
 Dec. 31 2021  0.02        0.03       0.03      Met     20
 ​​Sep.        0.03        0.02       0.02      Met     -14.3
 30 2021                                                
 Jun. 30 2021  0.02        0.02       0.00      Missed  -100​
 This summary was machine generated February 25 at 03:01 GMT. 
All figures in US dollars  unless otherwise stated